Defining a radiotherapy target with positron emission tomography
Top Cited Papers
- 15 November 2004
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 60 (4) , 1272-1282
- https://doi.org/10.1016/j.ijrobp.2004.06.254
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Value of whole-body FDG PET in management of lung cancerAnnals of Nuclear Medicine, 2003
- Positron emission tomography in lung cancerSeminars in Nuclear Medicine, 2002
- Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologistsRadiotherapy and Oncology, 2002
- Definition of gross tumor volume in lung cancer: inter-observer variabilityRadiotherapy and Oncology, 2002
- Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18 FDG-hybrid PET fusionInternational Journal of Radiation Oncology*Biology*Physics, 2001
- F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinomaCancer, 2001
- Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective StudyJournal of Clinical Oncology, 2001
- Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.Annals of Medicine, 2001
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999